This message was sent to ##Email##
|
|
|
|
| |
The International Transplant Nurses Society’s Annual Meeting Planning Committee invites you to submit an abstract for the Virtual Annual Meeting from Thursday, October 22 – Sunday, October 25 2020.
The online meeting format gives the planning committee the opportunity to add late breaking educational sessions to the program. Although we won’t see each other in-person this year, we’re hopeful this gives many an opportunity to present. Submit an abstract.
University of Pennsylvania School of Medicine via ScienceDaily
The self-eating process in embryonic stem cells known as chaperone-mediated autophagy and a related metabolite may serve as promising new therapeutic targets to repair or regenerate damaged cells and organs, Penn Medicine researchers show in a new study published online in Science.
READ MORE
Liver Transplantation
Standardized discharge criteria are critical to reduce the risk of premature discharge and avoid unnecessary days in hospital. No such criteria exist for patients who have undergone liver transplantation.
READ MORE
|
Promoted by
|
|
|
|
 |
Journal of Cardiac Failure
In patients with reduced kidney function there are no established guidelines to suggest combined heart-kidney transplant versus sequential kidney transplant using preoperative value of estimated glomerular filtration.
READ MORE
University of Chicago Medical Center via Medical Xpress
With the number of liver transplants performed at the University of Chicago Medicine on track to reach a 20-year high, a new study by the institution's researchers reinforces the growing popularity and safety of using livers infected with hepatitis C in transplants.
"Every year, several hundred people die while waiting for a donated liver in the United States," said Thomas Cotter, MD, a transplant hepatology fellow and first author of the study. "This research will help reassure patients that getting a liver from a donor with hepatitis C is as good as getting an uninfected liver."
READ MORE
 |
|
Promoted by
Veloxis Pharmaceuticals
Follow the journeys of kidney transplant patients who transitioned to a different immunosuppression regimen. After talking with their doctors about their experiences with other options, they decided to make a switch.
Watch video
|
|
Nephrology Times
Recipients of solid organ transplants commonly experience hyperkalemia, limiting use of pharmacotherapy in those patients. Hyperkalemia is associated with multifactorial causes, including kidney dysfunction, calcineurin inhibitor use, and infection prophylaxis. The effect of sodium zirconium cyclosilicate on potassium in the general population has been studied; however, the impact of SZ-9 on immunosuppression in transplant recipients is unknown.
READ MORE
American Journal of Nephrology via MD Linx
Since frailty prevalence as well as manifestation remain unclear among younger adults with end-stage kidney disease, disparities may exist depending on whether the patients received hemodialysis or kidney transplantation.
READ MORE
Advertisement
Veloxis Pharmaceuticals
There are many factors that may put a graft at risk, such as infections, nephrotoxicity, declining adherence, and inadequate immunosuppression. It can be difficult to achieve a balance between overimmunosuppression and underimmunosuppression in kidney transplant patients, putting patients at risk.
Learn More
|
The Lancet HIV
One of the primary risks of HIV-positive to HIV-positive organ transplantation is loss of virological control because of donor-derived HIV superinfection, which occurs when an HIV-positive individual becomes infected with a new distinct HIV strain. In this study, as part of the larger HIV Organ Policy Equity pilot study, HIV-positive to HIV-positive kidney and liver transplant recipients in the USA were examined for evidence of sustained donor-derived HIV superinfection.
READ MORE
The Journal of Heart and Lung Transplantation
Heart transplantation from ABO incompatible donors has evolved into a progressively accepted therapy in young children. Researchers assessed the recent practice of ABOi listing impact
on waitlist and post-transplant outcomes.
READ MORE
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
